These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6182257)

  • 1. [Effect of combined use of dextran sulfate and urokinase in cases of preeclampsia-behavior of blood coagulation-fibrinolysis and inhibitor systems].
    Mutoh S; Maki M; Takahashi S; Abe T
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Sep; 34(9):1519-27. PubMed ID: 6182257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fibrinolysis in pregnancy toxemia].
    Kano A
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Dec; 35(12):2311-20. PubMed ID: 6607299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on coagulation-fibrinolysis system and cold insoluble globulin in normal pregnancy (author's transl)].
    Mutoh S; Maki M; Takahashi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Mar; 34(3):369-77. PubMed ID: 7069251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies of coagulation-fibrinolysis system and cold insoluble globulin in cases of caesarean section].
    Mutoh S; Teh A; Shimoji Y; Nishi N; Saitoh M; Maki M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Oct; 37(10):2049-58. PubMed ID: 3878385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fibrinolytic therapy for toxemia of late pregnancy--experimental studies of pregnant rabbits treated with urokinase].
    Kano A
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jan; 36(1):72-80. PubMed ID: 6699451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood coagulation and fibrinolytic studies in patients with toxemia of pregnancy].
    Okamiya H
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Nov; 42(11):1557-64. PubMed ID: 2273312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of dextran sulfate in urokinase therapy and evaluation of the effects by estimation of plasmin inhibitor, fibrinogenolytic degradation products, and fibrinolytic degradation products.
    Hasegawa H; Nagata H; Yamauchi M; Murakoshi T; Oguma Y; Takei H; Seya T; Murao M
    Jpn Heart J; 1982 May; 23(3):339-47. PubMed ID: 6178853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
    J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in coagulation and fibrinolytic factors observed during heparin-urokinase-pulse combined therapy for nephritis resistant to conventional treatment in children].
    Koitabashi Y; Ikoma M; Shibawaka T; Yamaguchi Y; Mio H; Doi K; Meguro T; Yamada K
    Nihon Jinzo Gakkai Shi; 1993 Oct; 35(10):1155-61. PubMed ID: 7505345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled trial of combined urokinase and dextran sulfate therapy in patients with acute cerebral infarction.
    Fujishima M; Omae T; Tanaka K; Iino K; Matsuo O; Mihara H
    Angiology; 1986 Jul; 37(7):487-98. PubMed ID: 2425671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of fibrinolytic therapy of pulmonary thromboembolism using non-invasive examinations and the relationship of urokinase dosage to clinical outcome and coagulation-fibrinolytic changes.
    Oguma Y; Hasegawa H; Kawakami Y
    Jpn Circ J; 1988 Feb; 52(2):131-8. PubMed ID: 3361699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of coagulation and fibrinolysis system in pathogenesis of toxemia of pregnancy].
    Nakabayashi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Aug; 40(8):1000-9. PubMed ID: 2855231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation, fibrinolysis, platelet and kinin-forming systems during toxemia of pregnancy.
    Maki M
    Biol Res Pregnancy Perinatol; 1983; 4(4):152-4. PubMed ID: 6652168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on blood coagulation and fibrinolytic activities in the three cases of cerebral infarction treated with urokinase. 1st report--120,000 I.U. administrated-- (author's transl)].
    Fujita S; Itoga T; Shou T; Yamamoto H; Ishikawa H
    Rinsho Ketsueki; 1978 Jun; 19(6):850-8. PubMed ID: 713046
    [No Abstract]   [Full Text] [Related]  

  • 15. Coagulation index to distinguish severe preeclampsia from normal pregnancy.
    Kobayashi T; Sumimoto K; Tokunaga N; Sugimura M; Nishiguchi T; Kanayama N; Terao T
    Semin Thromb Hemost; 2002 Dec; 28(6):495-500. PubMed ID: 12536338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of coagulation parameters on the placental respiratory and nutritive function in women having chronic hypertension with superimposed preeclampsia.
    Djelmis J; Kendić S; Buković D; Pfeifer D; Ivanisević M
    Coll Antropol; 1997 Jun; 21(1):127-37. PubMed ID: 9225506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation-fibrinolytic and kinin-forming systems in toxemia of pregnancy.
    Hayakawa M; Maki M
    Gynecol Obstet Invest; 1988; 26(3):181-90. PubMed ID: 3240888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The changes of alpha 2-plasmin inhibitor, and notably urokinase activities in blood measured by synthetic chromogenic substrates S-2444 after urokinase administration].
    Itoh Y; Tsuji K; Tanaka N; Yamada M; Nakanishi M; Ishihara M; Kobayashi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jan; 35(1):68-76. PubMed ID: 6338134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of placental urokinase inhibitor in toxemia of pregnancy.
    Terao T; Kobayashi T
    Biol Res Pregnancy Perinatol; 1983; 4(4):145-51. PubMed ID: 6360225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Coagulation-fibrinolysis and kinin-forming systems in toxemia of pregnancy].
    Hayakawa M
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Jan; 40(1):59-66. PubMed ID: 3351365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.